1. Home
  2. LXU vs EVO Comparison

LXU vs EVO Comparison

Compare LXU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$11.33

Market Cap

878.4M

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.59

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXU
EVO
Founded
1968
1993
Country
United States
Germany
Employees
513
4553
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
878.4M
994.5M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
LXU
EVO
Price
$11.33
$2.59
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$14.63
$7.00
AVG Volume (30 Days)
740.4K
28.6K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
225.93
N/A
EPS
0.27
N/A
Revenue
$615,208,000.00
N/A
Revenue This Year
$13.69
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
$42.02
N/A
Revenue Growth
17.77
N/A
52 Week Low
$7.09
$2.31
52 Week High
$17.22
$4.42

Technical Indicators

Market Signals
Indicator
LXU
EVO
Relative Strength Index (RSI) 33.35 38.27
Support Level $8.07 $2.32
Resistance Level $15.56 $3.82
Average True Range (ATR) 0.50 0.07
MACD -0.05 -0.02
Stochastic Oscillator 6.54 2.02

Price Performance

Historical Comparison
LXU
EVO

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: